Home
/
(0.36*60 Tablets*3 boxes/lot). Fufang Danzhi Pian For stroke. Fufang Danzhi Tablets. Fu Fang Dan Zhi Pian
(0.36*60 Tablets*3 boxes/lot). Fufang Danzhi Pian For stroke. Fufang Danzhi Tablets. Fu Fang Dan Zhi Pian
Quantity
Detail
Customer Reviews
Generic name: compound Danzhi tablets
Chinese Pinyin: Fufang Danzhi Pian
Product name: spring flower
Ingredients: Astragalus, Danshen, Leech, Earth Dragon, Chuanqiong.
Properties: This product is a film-coated tablet. After removing the film-coating, it looks brown; it tastes bitter and slightly astringent.
Functions and indications: Replenishing qi and dredging collaterals, promoting blood circulation and removing blood stasis. It is used for the syndrome of qi deficiency and blood stasis in the meridian during the recovery period of arteriosclerotic thrombotic cerebral infarction. Symptoms include hemiplegia, crooked mouth and tongue, astringent language, partial body numbness, shortness of breath, fatigue, dizziness, and cerebral infarction recovery period. By.
Specifications: Each piece weighs 0.36g
Usage and dosage: Oral. 5 tablets at a time, 3 times a day for 6 weeks.
Adverse reactions: Abdominal pain occurred in individual cases after taking the medicine.
Contraindications: Contraindications for cerebral hemorrhage. Not for pregnant women.
Note: Take after meals.
Pharmacology and Toxicology: The oral administration of this product can resist the increase of cerebral vascular permeability after cerebral ischemia in rats with bilateral common carotid artery ligation, and reduce the brain water content, reduce cerebral atrophy-like changes caused by ischemia; can inhibit The formation of arterial thrombosis in rats, reduces the platelet adhesion rate, inhibits ADP-induced platelet aggregation, shortens the dissolution time of euglobulin, and reduces the blood viscosity, hematocrit and fiber of the dexamethasone-induced "blood stasis" model rats Proteinogen.
Storage: Airtight, moisture-proof.
Packing: PTP aluminum foil for medicine packaging, PVC hard film for medicine, 15 pieces×4 boards/box.
Validity period: 24 months
Approval number: National Medicine Standard Z20010114
Company Name: Tonghua Baishan Pharmaceutical Co., Ltd.
Chinese Pinyin: Fufang Danzhi Pian
Product name: spring flower
Ingredients: Astragalus, Danshen, Leech, Earth Dragon, Chuanqiong.
Properties: This product is a film-coated tablet. After removing the film-coating, it looks brown; it tastes bitter and slightly astringent.
Functions and indications: Replenishing qi and dredging collaterals, promoting blood circulation and removing blood stasis. It is used for the syndrome of qi deficiency and blood stasis in the meridian during the recovery period of arteriosclerotic thrombotic cerebral infarction. Symptoms include hemiplegia, crooked mouth and tongue, astringent language, partial body numbness, shortness of breath, fatigue, dizziness, and cerebral infarction recovery period. By.
Specifications: Each piece weighs 0.36g
Usage and dosage: Oral. 5 tablets at a time, 3 times a day for 6 weeks.
Adverse reactions: Abdominal pain occurred in individual cases after taking the medicine.
Contraindications: Contraindications for cerebral hemorrhage. Not for pregnant women.
Note: Take after meals.
Pharmacology and Toxicology: The oral administration of this product can resist the increase of cerebral vascular permeability after cerebral ischemia in rats with bilateral common carotid artery ligation, and reduce the brain water content, reduce cerebral atrophy-like changes caused by ischemia; can inhibit The formation of arterial thrombosis in rats, reduces the platelet adhesion rate, inhibits ADP-induced platelet aggregation, shortens the dissolution time of euglobulin, and reduces the blood viscosity, hematocrit and fiber of the dexamethasone-induced "blood stasis" model rats Proteinogen.
Storage: Airtight, moisture-proof.
Packing: PTP aluminum foil for medicine packaging, PVC hard film for medicine, 15 pieces×4 boards/box.
Validity period: 24 months
Approval number: National Medicine Standard Z20010114
Company Name: Tonghua Baishan Pharmaceutical Co., Ltd.